Here are 12 key notes on orthopedic and spine device companies over the past week.
Carlsbad, Calif.-based Alphatec made changes to its executive leadership team as well as updated its compliance status with Nasdaq's listing requirements.
The Journal of the American Medical Association published the pivotal trial results for Medtronic's Hybrid Closed Loop system.
Ronda Stryker, the director of Stryker, sold 12,000 shares of the business's stock for $1,354,200.
New research yielded positive results for Smith & Nephew's PICO Single Use Negative Pressure Wound Therapy.
San Diego-based NuVasive received FDA clearance for the use of its Reline posterior fixation system to implant the MAGEC system.
A surgeon performed the first spine surgery using Band-LOK's pedicle-sparing polyester band spinal technology.
Alphatec reached an all-time 52-week high on Sept. 20 with a price target of $10.22, which is 63 percent above the day's share price of $6.27.
The FDA cleared the use of K2M's screw and connector components for its Mesa Spinal System.
The Warsaw, Ind.-based medical device company Zimmer Biomet launched Vanguard Individualized Design, a new total knee arthroplasty implant.
The FDA cleared Carestream’s OnSight 3D Extremity System, allowing it to be sold in the United States.
Germany-based SHS Gesellschaft für Beteiligungsmanagement is investing in EIT Emerging Implant Technology.
The FDA cleared Life Spine's PRO-LINK Ti Stand-Alone Cervical Spacer System.